Ciric Danica, Richard Charles-Adrien, Moudjou Mohammed, Chapuis Jérôme, Sibille Pierre, Daude Nathalie, Westaway David, Adrover Miguel, Béringue Vincent, Martin Davy, Rezaei Human
National Institute for Agricultural Research (INRA), Pathological Macro-Assemblies and Prion Pathology Group (MAP), UR892, Virologie Immunologie Moléculaires, Jouy-en-Josas, France.
University of Alberta, Centre for Prion and Protein Folding Diseases, Research in Neurodegenerative Diseases, Edmonton, AB, Canada.
J Virol. 2015 Jun;89(12):6287-93. doi: 10.1128/JVI.03429-14. Epub 2015 Apr 8.
Prion diseases are characterized by conformational changes of a cellular prion protein (PrP(C)) into a β-sheet-enriched and aggregated conformer (PrP(Sc)). Shadoo (Sho), a member of the prion protein family, is expressed in the central nervous system (CNS) and is highly conserved among vertebrates. On the basis of histoanatomical colocalization and sequence similarities, it is suspected that Sho and PrP may be functionally related. The downregulation of Sho expression during prion pathology and the direct interaction between Sho and PrP, as revealed by two-hybrid analysis, suggest a relationship between Sho and prion replication. Using biochemical and biophysical approaches, we demonstrate that Sho forms a 1:1 complex with full-length PrP with a dissociation constant in the micromolar range, and this interaction consequently modifies the PrP-folding pathway. Using a truncated PrP that mimics the C-terminal C1 fragment, an allosteric binding behavior with a Hill number of 4 was observed, suggesting that at least a tetramerization state occurs. A cell-based prion titration assay performed with different concentrations of Sho revealed an increase in the PrP(Sc) conversion rate in the presence of Sho. Collectively, our observations suggest that Sho can affect the prion replication process by (i) acting as a holdase and (ii) interfering with the dominant-negative inhibitor effect of the C1 fragment.
Since the inception of the prion theory, the search for a cofactor involved in the conversion process has been an active field of research. Although the PrP interactome presents a broad landscape, candidates corresponding to specific criteria for cofactors are currently missing. Here, we describe for the first time that Sho can affect PrP structural dynamics and therefore increase the prion conversion rate. A biochemical characterization of Sho-PrP indicates that Sho acts as an ATP-independent holdase.
朊病毒疾病的特征是细胞朊病毒蛋白(PrP(C))构象转变为富含β-折叠且聚集的构象异构体(PrP(Sc))。朊病毒蛋白家族成员沙杜(Sho)在中枢神经系统(CNS)中表达,在脊椎动物中高度保守。基于组织解剖学共定位和序列相似性,怀疑Sho和PrP可能在功能上相关。如双杂交分析所揭示的,在朊病毒病理学过程中Sho表达下调以及Sho与PrP之间的直接相互作用,提示了Sho与朊病毒复制之间的关系。利用生化和生物物理方法,我们证明Sho与全长PrP形成1:1复合物,解离常数在微摩尔范围内,并且这种相互作用进而改变了PrP的折叠途径。使用模拟C末端C1片段的截短PrP,观察到具有4的希尔系数的变构结合行为,表明至少发生了四聚化状态。用不同浓度的Sho进行的基于细胞的朊病毒滴定分析显示,在Sho存在下PrP(Sc)转化率增加。总体而言,我们的观察结果表明,Sho可通过以下方式影响朊病毒复制过程:(i)作为分子伴侣结合蛋白发挥作用;(ii)干扰C1片段的显性负抑制剂效应。
自朊病毒理论提出以来,寻找参与转化过程的辅助因子一直是一个活跃的研究领域。尽管PrP相互作用组呈现出广阔的图景,但目前缺少符合辅助因子特定标准的候选物。在这里,我们首次描述Sho可影响PrP结构动力学,从而提高朊病毒转化率。Sho-PrP的生化特征表明,Sho作为一种不依赖ATP的分子伴侣结合蛋白发挥作用。